Snapshot · Russell 3000 · generated 2026-11-11 21:49 UTC
JANX — Janux Therapeutics, Inc.
N/A · Quality 39/100
Value Score 30 days ago: 14.5 → today 26.8
Price
12.39
Intrinsic value
-
no positive per-share earnings - the P/E-blend method needs a profit to value
Margin of safety
-
Implied growth (reverse DCF)
-
a described calculation from stated inputs, not a forecast
Value Score
26.8
Quality
39
Psychology
38.8
Discovery
44.4
price/volume attention only
Moat score
0
erosion: none
Value Score: bottom 34% of Russell 3000 · Quality: bottom 25%
Open the interactive Deep Dive for JANX →
Use this data programmatically
This page's numbers are also available as JSON at /api/v1/deep-dive/JANX - see the API docs for the full read-only surface, including an MCP server for AI assistants.
Common questions
What is Janux Therapeutics, Inc.'s Value Score?
Janux Therapeutics, Inc.'s Value Score is 26.8 as of 2026-11-11 - it combines value, quality, crowd psychology and market attention into one number. This is a described calculation from public data, not a recommendation.